Multiple US-based systems for risk stratification of thyroid nodules are in use worldwide.
Unfortunately, the malignancy probability assigned to a nodule varies, and terms and …

The treatment paradigm for thyroid cancer has shifted from a one-size-fits-all approach to
more personalized protocols that range from active surveillance to total thyroidectomy …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Modern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid
cancer (DTC) should be implemented in line with patients' risk stratification. Although …

Background In ESTIMABL1, a randomised phase 3 trial of radioactive iodine (131 I)
administration after complete surgical resection in patients with low-risk thyroid cancer, 92 …

An ever-increasing population of patients with papillary thyroid cancer is engaging with
health care systems around the world. Numerous questions about optimal management …

Background: The most frequent site of recurrence of differentiated thyroid cancer (DTC) is
cervical lymph nodes (LNs), which often necessitates repeated surgical interventions and …

Context The risk stratification of patients with differentiated thyroid cancer (DTC) is crucial in
clinical decision making. The most widely accepted method to assess risk of …

Background: One of the most widely used risk stratification systems for estimating individual
patients' risk of persistent or recurrent differentiated thyroid cancer (DTC) is the American …

Context: Trends toward more conservative management of papillary thyroid cancer (PTC)
diminish the primacy of serum thyroglobulin (Tg) assays as a posttreatment surveillance tool …